EUVIMEDSkopri EUVIMED
Randomisierte kontrollierte StudieStudienprotokollOpen access

Evaluating the Efficacy of a Mobile Phone App in Enhancing Menopause Knowledge and Shared Decision-Making: Protocol for a Randomized Controlled Trial

Jana Karam iD, Maggie M Paul iD, Chrisandra Shufelt iD, Prajna Ravikumar iD, Amy M Fratianni iD, Sey Oloyede iD, Erin M Pagel iD, Mary S Hedges iD, Ekta Kapoor iD, Juliana M Kling iD, Kristin Cole iD, Rajeev Chaudhry iD and 1 more

JMIR Research Protocols · 2025

DOI: 10.2196/76536 ↗

At a glance

Randomisierte kontrollierte Studie in JMIR Research Protocols, 2025. Written by Jana Karam and 12 co-authors. Institution: Mayo Clinic in Florida, Jacksonville, FL, United States. Major MEDLINE topics: Menopause, Mobile Applications, Decision Making, Shared, Patient Education as Topic. Cited 4 times so far (Crossref); 29 references. The full text is freely available in PubMed Central.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Menopause symptoms are common but often inadequately addressed by primary care clinicians due to limited time for discussions and resources. Mobile health apps can play a crucial role in symptom identification and management; yet, many existing menopause-focused apps lack evidence-based content and medical expertise.

Objective

The aim of this study is to describe the protocol study design and methodology of a randomized controlled trial to evaluate the effectiveness of the emmii mobile app for improving menopause-related knowledge and shared decision-making compared to a traditional menopause education pamphlet.

Methods

This randomized controlled trial will recruit women aged 45-55 years with upcoming primary care appointments at Mayo Clinic within 3 weeks of the date of initial outreach. Eligible patients must be English-speaking, able to provide informed consent, and report a Menopause Rating Scale score ≥5, which indicates that they are experiencing significant menopause-related symptoms. Patients will be randomized to have access to either the emmii app (intervention, n=200) or an evidence-based menopause education pamphlet (control, n=200). The emmii app is developed with direct input from primary care clinicians certified by The Menopause Society and offers symptom tracking, personalized treatment recommendations based on a protocol, and a discussion guide to support communication between patients and their primary care clinicians. Outcomes will include a postappointment survey sent to the patients and their primary care clinicians within 1-3 weeks of the appointment, and assessment of patient knowledge, clinical treatment plans, and both the patient and clinician experience. The study will also compare prescribing rates of hormonal and nonhormonal therapies for menopause symptoms between the emmii intervention and control groups to assess for influence on treatment patterns. Data will be analyzed using descriptive statistics, including chi-square tests, Wilcoxon rank sum tests, and multivariable modeling.

Results

Data collection is scheduled to begin in April 2025.

Conclusions

This protocol outlines the design and methodology of a randomized controlled trial that aims to assess the impact of the emmii app in facilitating menopause care through primary care clinician–patient communication and shared decision-making. Trial Registration ClinicalTrials.gov NCT06919887; https://clinicaltrials.gov/ct2/show/NCT06919887 International Registered Report Identifier (IRRID) PRR1-10.2196/76536

Subjects

MeSH terms (MEDLINE)

MenopauseMobile ApplicationsDecision Making, SharedPatient Education as TopicHealth Knowledge, Attitudes, PracticeHumansFemaleMiddle AgedRandomized Controlled Trials as TopicPrimary Health Care

Author keywords

RCTdigital healthmHealthmenopausemobile appmobile healthrandomized controlled trial

Authors and institutions

  • Mayo Clinic in Florida, Jacksonville, FL, United States.
  • Women's Health Department, Mayo Clinic, Rochester, MN, United States.
  • Robert D and Patricia E Kern Center for the Science of Health Care Delivery, Mayo Clinic in Arizona, Phoenix, AZ, United States.
  • Division of Community Internal Medicine, Mayo Clinic in Florida, Jacksonville, FL, United States.
  • Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN, United States.
  • Division of Women's Health Internal Medicine, Mayo Clinic in Arizona, Scottsdale, AZ, United States.

ORCID profiles: Jana Karam, Maggie M Paul, Chrisandra Shufelt, Prajna Ravikumar, Amy M Fratianni, Sey Oloyede, Erin M Pagel, Mary S Hedges, Ekta Kapoor, Juliana M Kling, Kristin Cole, Rajeev Chaudhry, Stephanie S Faubion

Cite

APA

Karam, J., Paul, M. M., Shufelt, C., Ravikumar, P., Fratianni, A. M., Oloyede, S., Pagel, E. M., Hedges, M. S., Kapoor, E., Kling, J. M., Cole, K., Chaudhry, R., & Faubion, S. S. (2025). Evaluating the Efficacy of a Mobile Phone App in Enhancing Menopause Knowledge and Shared Decision-Making: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/76536

Vancouver

Karam J, Paul MM, Shufelt C, Ravikumar P, Fratianni AM, Oloyede S, et al. Evaluating the Efficacy of a Mobile Phone App in Enhancing Menopause Knowledge and Shared Decision-Making: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 2025. doi:10.2196/76536

BibTeX
@article{Karam2025,
  author = {Karam, Jana and Paul, Maggie M and Shufelt, Chrisandra and Ravikumar, Prajna and Fratianni, Amy M and Oloyede, Sey and Pagel, Erin M and Hedges, Mary S and Kapoor, Ekta and Kling, Juliana M and Cole, Kristin and Chaudhry, Rajeev and Faubion, Stephanie S},
  title = {Evaluating the Efficacy of a Mobile Phone App in Enhancing Menopause Knowledge and Shared Decision-Making: Protocol for a Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/76536}
}
Start for free →